Bausch Health Companies (BHC) Scheduled to Post Earnings on Thursday

Bausch Health Companies (TSE:BHC) will post its quarterly earnings results before the market opens on Thursday, August 1st. Analysts expect Bausch Health Companies to post earnings of C$1.22 per share for the quarter.

Bausch Health Companies (TSE:BHC) last posted its quarterly earnings data on Thursday, May 2nd. The company reported C$0.80 earnings per share for the quarter, missing the consensus estimate of C$1.02 by C($0.22). The firm had revenue of C$2.90 billion for the quarter, compared to the consensus estimate of C$2.98 billion. Bausch Health Companies had a negative return on equity of 686.52% and a negative net margin of 5.07%.

Bausch Health Companies Stock Up 0.2 %

BHC stock opened at C$8.26 on Wednesday. The company has a debt-to-equity ratio of 7,583.76, a current ratio of 1.23 and a quick ratio of 0.58. The stock has a market capitalization of C$3.03 billion, a price-to-earnings ratio of -4.89, a PEG ratio of 0.21 and a beta of 0.90. The business’s fifty day moving average price is C$9.16 and its two-hundred day moving average price is C$10.84. Bausch Health Companies has a fifty-two week low of C$5.45 and a fifty-two week high of C$15.43.

Analyst Ratings Changes

Separately, Raymond James upgraded Bausch Health Companies to a “hold” rating in a research report on Wednesday, July 10th.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.